ATHX
Athersys Inc
Halal Rating :
Last Price
$0.00
Last updated:
Market Cap
-
7D Change
0.0%
1 Year Change
0.0%
Company Overview
Industries
Exchange
Next Earnings Date
Athersys, Inc. is a biotechnology company focused on developing and commercializing novel therapies for medical conditions with significant unmet needs. Their lead product candidate, MultiStem, is an 'off-the-shelf' stem cell product being developed for treating various diseases and conditions including ischemic stroke, trauma, and inflammatory and immune disorders. The company is primarily in the research and development phase, with minimal revenue generation from collaborative arrangements.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| June 30, 2023 | $49000.0 | $13.04m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Athersys Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.